Montelukast: Pharmacology, Safety, Tolerability and Efficacy

被引：0

作者：

Benninger, Michael S. ^{[1
]}

Waters, Heather ^{[1
]}

机构：

[1] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44106 USA

来源：

CLINICAL MEDICINE INSIGHTS-THERAPEUTICS | 2009年 / 1卷

关键词：

allergic rhinitis; asthma; montelukast;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Allergic rhinitis and asthma are common disorders effecting large percentages of the population of Western countries. There are multiple treatment options available for allergic rhinitis and asthma and stepwise approaches to therapy have been recommended. Montelukast is a cysteinyl leukotriene receptor antagonist that has been found to be effective both in the treatment of allergic rhinitis and asthma. This paper will describe the pharmacology, safety, efficacy and tolerability of montelukast. It will examine the comparative efficacy of montelukast to other medications for the treatment of allergic rhinitis and asthma, as well as discuss the recent studies of combination therapy.

引用

页码：1253 / 1261

页数：9

共 65 条

[1] Zafirlukast-related hepatitis: report of a further case [J].

Actis, GC ;

Morgando, A ;

Lagget, M ;

David, E ;

Rizzetto, M .

JOURNAL OF HEPATOLOGY, 2001, 35 (04) :539-541

[2]

AstraZeneca Pharmaceuticals W Del, DEL ACC ZAF PROD INF

[3]

Benninger MS, 2009, ALLERGY ASTHMA P

[4] Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study [J].

Borderias, Luis ;

Mincewicz, Grzegorz ;

Paggiaro, Pier Luigi ;

Guilera, Magda ;

Kocevar, Vasilisa Sazonov ;

Taylor, Stephanie D. ;

Badia, Xavier .

CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) :721-730

[5] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) [J].

Bousquet, J. ;

Khaltaev, N. ;

Cruz, A. A. ;

Denburg, J. ;

Fokkens, W. J. ;

Togias, A. ;

Zuberbier, T. ;

Baena-Cagnani, C. E. ;

Canonica, G. W. ;

van Weel, C. ;

Agache, I. ;

Ait-Khaled, N. ;

Bachert, C. ;

Blaiss, M. S. ;

Bonini, S. ;

Boulet, L. -P. ;

Bousquet, P. -J. ;

Camargos, P. ;

Carlsen, K. -H. ;

Chen, Y. ;

Custovic, A. ;

Dahl, R. ;

Demoly, P. ;

Douagui, H. ;

Durham, S. R. ;

van Wijk, R. Gerth ;

Kalayci, O. ;

Kaliner, M. A. ;

Kim, Y. -Y. ;

Kowalski, M. L. ;

Kuna, P. ;

Le, L. T. T. ;

Lemiere, C. ;

Li, J. ;

Lockey, R. F. ;

Mavale-Manuel, S. ;

Meltzer, E. O. ;

Mohammad, Y. ;

Mullol, J. ;

Naclerio, R. ;

Hehir, R. E. O. ;

Ohta, K. ;

Ouedraogo, S. ;

Palkonen, S. ;

Papadopoulos, N. ;

Passalacqua, G. ;

Pawankar, R. ;

Popov, T. A. ;

Rabe, K. F. ;

Rosado-Pinto, J. .

ALLERGY, 2008, 63 :8-+

[6] Cysteinyl leukotrienes in allergic inflammation - Strategic target for therapy [J].

Busse, W ;

Kraft, M .

CHEST, 2005, 127 (04) :1312-1326

[7] Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr [J].

Chen, ST ;

Lu, KH ;

Sun, HL ;

Chang, WT ;

Lue, KH ;

Chou, MC .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (01) :49-54

[8] Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies [J].

Chervinsky, P ;

Philip, G ;

Malice, MP ;

Bardelas, J ;

Nayak, A ;

Marchal, JL ;

van Adelsberg, J ;

Bousquet, J ;

Tozzi, CA ;

Reiss, TF .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (03) :367-373

[9] Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis [J].

Ciebiada, Maciej ;

Gorska-Ciebiada, Malgorzata ;

DuBuske, Lawrence A. ;

Gorski, Pawel .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (05) :664-671

[10] PEPTIDE LEUKOTRIENE RELEASE AFTER ANTIGEN CHALLENGE IN PATIENTS SENSITIVE TO RAGWEED [J].

CRETICOS, PS ;

PETERS, SP ;

ADKINSON, NF ;

NACLERIO, RM ;

HAYES, EC ;

NORMAN, PS ;

LICHTENSTEIN, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (25) :1626-1630

← 1 2 3 4 5 6 7 →